Delivering Chemotherapy Drugs Directly into Cancer Cells While Minimizing Harm – Peptinovo Biopharma Inc.

Delivering Chemotherapy Drugs Directly into Cancer Cells While Minimizing Harm

Ren Homan, Ph.D., Co-Founder of Peptinovo Biopharma and Steve Tokarz, CEO of Peptinovo Biopharma

Verschlagwortet biopharmaceutical, biotech, biotechnology, chemotherapy drugs, Dr. Ren Homan, Human Research Ethics Committees (HRECs), human trials, nanotechnology platform, paclitaxel, PALM™ (Peptide-Amphiphile Lipid Micelle), Peptinovo Biopharma, smart drug delivery vehicle, synthetic HDL, synthetic vitamin E compound, synthetic vitamin E prodrug linker, targeted chemotherapy, thepatientiswaiting